NCT00460577

Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction

Randomized, Double Blind, Double Dummy, Placebo Controlled Trial to Compare the Effectiveness of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Asthmatic Children (5-<12 Years) With Acute Bronchial Obstruction Attending Emergency Services

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 5 Years – 12 Years
• Healthy volunteers: Not accepted

Summary

To determine efficacy and tolerability of inhaled Formoterol vs nebulized Ipatropioum Bromide plus Fenoterol in cumulative sequential doses in asthmatic children (5-\<12 years) with acute bronchial obstruction attending emergency services

Conditions

• Acute Bronchial Obstruction, Asthma

Interventions

Type	Name	Description
DRUG	Formoterol fumerate	12 micrograms stat (twice if necessary). Inhaled via aerolizer
DRUG	fenoterol/ipratropium bromide	0.5 micrograms/0.25 milligrams (20 drops) inhaled via nebulization diluted in 3cc of 0.9% saline.

Timeline

• Start date: 2007-03-01
• Primary completion: 2008-09-01
• Completion: 2008-09-01
• First posted: 2007-04-16
• Last updated: 2011-04-19
• Results posted: 2011-04-19

Locations

2 sites across 1 country: Venezuela